Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
Status:
Completed
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to define a safe and effective dose of iontophoretic delivery of
dexamethasone phosphate ophthalmic solution using the EyeGate® II Drug Delivery System in
patients with non-infectious anterior segment uveitis.